Order Article Reprints

Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD. Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells. Antioxidants. 2022; 11(3):513. https://doi.org/10.3390/antiox11030513

Demircan, Muhammed Burak, Peter C. Mgbecheta, Anne Kresinsky, Tina M. Schnoeder, Katrin Schröder, Florian H. Heidel, and Frank D. Böhmer. 2022. "Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells" Antioxidants 11, no. 3: 513. https://doi.org/10.3390/antiox11030513

Demircan, M. B., Mgbecheta, P. C., Kresinsky, A., Schnoeder, T. M., Schröder, K., Heidel, F. H., & Böhmer, F. D. (2022). Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells. Antioxidants, 11(3), 513. https://doi.org/10.3390/antiox11030513